Skip to main content
Caplight Logo









Folium Science

Folium Science

Private
BristolHealthcare & Life Scienceshttps://foliumscience.com

Last Round

Grant

Feb 12, 2024

Total Funding Raised

$756,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Folium Science is a UK-based biotechnology company founded in 2016 that develops a CRISPR-Cas based technology, Guided Biotics®, to selectively remove harmful bacteria in livestock to reduce antibiotic use and improve agricultural productivity.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

antibiotic alternativeCRISPR-based antimicrobialfeed additivemicrobiome editingagricultural biotechnologyantimicrobial resistanceAMRlivestock healthpathogen controlAgTechSalmonella controlfood safety technologypoultry healthdiagnostic biosensortechnology licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Folium Science Comparables

Compare Folium Science with similar companies based on industry and business-model similarity.

Folium Science comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NovoBind Livestock Therapeutics Inc.
81%
PhageLab
81%
Proteon Pharmaceuticals
80%

Folium Science Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 12, 2024
GrantFeb 1, 2024
StrategicMay 18, 2022
GrantAug 26, 2020
GrantJul 6, 2019
Accelerator
May 1, 2019

Folium Science Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 52% MoM.

  • Apr 17, 2026

    Monthly visitors grew 186% MoM, reaching 2.1K.

Recent news

Latest coverage and updates

  • sells_assets_toAug 25, 2026

    Folium Science sold assets to BiomEdit, Inc. on Aug 25th '26.

Folium Science Filings

Explore SEC and related filing metadata, where available.

Folium Science filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Folium Science's valuation, stock price, and market status.

Is Folium Science a public or private company?

Folium Science is a private company.

What is the current stock price of Folium Science?

Folium Science is a private company with no public stock price. No recent secondary market data is available.

How much is Folium Science worth (valuation)?

Valuation information for Folium Science is not publicly available.

Can I buy Folium Science stock?

Folium Science shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Folium Science's last funding round?

Folium Science's most recent funding round was Grant on February 12, 2024.

Who are the main investors in Folium Science?

Key investors in Folium Science include Lundbeckfonden BioCapital.

Will Folium Science IPO soon?

No public IPO plans have been announced for Folium Science.

How can I track Folium Science secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Folium Science's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBristol
Employee Range13
Year Founded2016
Last FundingFeb 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?